Neous Therapeutics Revenue, Profits - NEOS Annual Income Statement

Add to My Stocks
$5 $0 (0%) NEOS stock closing price Sep 21, 2018 (Closing)

NEOS stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Neous Therapeutics stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 9.15M to 25.01M and how operating and non operating activities have impacted the NEOS stock. The operating expenses as shown in the Neous Therapeutics profit and loss statement for 2017 total to $69.63M. This line item shows that the operating expenses has decreased compared with last year. Also check: Neous Therapeutics assets and Neous Therapeutics free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20172016201520142013
Neous Therapeutics Revenues or Net Sales
25.01M9.15M3.79M-1.04M
Cost Of Goods Sold (COGS)12.39M11.43M5.54M3.35M2.53M
Neous Therapeutics Gross Profit
12.62M-2.28M-1.75M-2.59M-1.49M
Research & Development Expense8.95M12.2M11.88M10.6M9.97M
Selling General & Admin Expense60.68M61.91M12.93M5.27M5.62M
Income Before Depreciation Depletion Amortization-57.01M-76.4M-26.57M-18.47M-17.08M
Depreciation Depletion Amortization-----
Non Operating Income---0.48M--
Interest Expense10.08M6.93M3.72M2.95M2.11M
Neous Therapeutics Pretax Income
-66.24M-83.33M-30.78M-20.84M-18.6M
Provision for Income Taxes-----
MinorityInterest-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-66.24M-83.33M-30.78M-20.84M-18.6M
Extraordinary Items & Discontinued Operations-----0.43M
Neous Therapeutics Profit/ Loss (Net Income)
-66.24M-83.33M-30.78M-20.84M-19.03M
Average Shares used to compute Diluted EPS24.75M16.05M7.58M--
Average Shares used to compute Basic EPS24.75M16.05M7.58M--
Income Before Nonrecurring Items-66.25M-83.33M-30.78M-20.85M-
Income from Nonrecurring Items-----
Neous Therapeutics Earnings Per Share Basic Net
-2.68-5.19-4.38-27.56-
Neous Therapeutics Earnings Per Share Diluted Net
-2.68-5.19-4.38-27.56-
EPS Diluted Before Nonrecurring Items-2.68-5.19-4.38-27.56-
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Neous Therapeutics stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Neous Therapeutics revenue chart implies that the company is growing. It has been the case with Neous Therapeutics. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-66.24M for NEOS stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The NEOS financials along with Neous Therapeutics historical stock prices provide a lot of details about the firm.

Neous Therapeutics Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.97
Dividend Yield
0%